PTC Therapeutics | PTCT - Ativos

Preço das Ações
68.23
Mudança Diária
-0.36 -0.52%
Mensal
2.22%
Anual
37.75%
Q2 Previsão
66.77




Ativos Alterar Data
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xencor USD 875.5M 6.68M 2025-12